|
|
Title |
Maximum Requested Budget |
Renewable? |
Targeted applicants |
|
Research Grant |
$55K for one year ($50K direct costs, $5K indirect costs) |
No. Re-applications will be reviewed as a new application. |
Faculty, either MD and/or PhD - |
|
Fellowship Grant |
$44,000 per year–up to $35K stipend–$5K supplies–$4K indirect costs) |
No. Re-applications will be reviewed as a new application. |
Clinical fellows, residents, post-doctoral fellows (both MD and PhD), and graduate students. |
|
Clinical Investigations Grant |
$66K for one year ($60K direct costs, $6K indirect costs) |
There is a possibility for renewal for a second year, but applications will be reviewed competitively as a new application. |
Anybody -Those WITHOUT major funding (<$100,000 for any project) (NIH, DoD, NSF) encouraged to apply |
|
Clinician-Scientist Award |
Up to $240K over 3 years ($80K per year)–Up to $70K per year for salary–Up to $20K per year for supplies & equipment |
A progress report is required for every year of funding, but the grant will typically be renewed unless something untoward happens or the PI gets a K08/K23 Award. |
Full-time teaching appointment (MD), typically at a junior level who are aiming to develop a career as a clinician-scientist |
|
Multi-centered Clinical Cooperative Seed Grant NEW in 2026
|
$55K for one year; no indirect costs allowed | There is a possibility for renewal for a second year, but applications will be reviewed competitively as a new application. | AOS membership REQUIRED for PI, minimum of 3 collaborating sites. Neither the overall PI nor the Site PIs may be trainees. Only 1 award per year to be distributed. Concurrent NIH R13 grant may be applied for/awarded, but PIs with larger awards for study of the same disease are ineligible to apply. A history of significant funding in areas of research other than the proposed multi-site research will not disqualify the applicants. |
THESE DATES APPLY TO ALL AOS GRANT MECHANISMS
LOI DUE MONDAY, NOVEMBER 3, 2025
If you would like to submit a grant for consideration of funding in the next cycle, 2026-2027, in ONE PDF, include a LETTER OF INTENT and PI BIOSKETCH (NIH template), including details regarding other existing support, and any potential overlap with your mentor(s) must be submitted by November 1st (Nov 3rd in 2025) of the year prior to funding. The letter of intent must state the desired grant mechanism for the proposal (CSA, Fellowship grant, Clinical Investigation, or Research grant), the Principal Investigator, and Institution(s), a working title, with an abstract and Specific Aims (2 page limit on abstract and aims). Biosketches and a cover letter should accompany the 2 page proposal summary (in addition to the abstract/aims), but it is not included as part of the two page summary. The next funding cycle begins July 1, 2026. Biosketches of all personnel are optional, but will be required if invited to submit a full application.
Complete applications will be invited from selected applicants based on the Research Advisory Board's review of the letters of intent. Applicants will be notified whether they are invited to submit a full application the first week of December.
Click here to view "Fast facts and Q&A about all AOS Grant mechanisms
Click here to open the AOS grant submission instructions (pdf) (UPDATED JULY 2025)
Click here for more information about the AOS Clinician Scientist Award and renewal guidelines
Budget and Salary support Q&A
Fellowship Grant - up to $35K
Clinician Scientist Award - up to $70K
NO salary support for Research grants or Clinical Investigation grants.

2025-26 AOS Research Advisory Board
Andrea Vambutas, MD, Executive Secretary
Richard K. Gurgel, MD, MSCI, Trustee, Executive Secretary-Elect
Samuel Gubbels, MD, Trustee
Ronna Hertzano, MD, PhD Trustee
Wade W. Chien, MD, Trustee
Sharon Cushing, MD, MSc, Trustee
Rick Nelson, MD, PhD, Trustee
Lina A. J. Reiss, PhD, Consultant
Radha Kalluri, PhD, Consultant
Hari Bharadwaj, PhD, Consultant
The Research Advisory Board (RAB) is comprised of seven AOS members, each serving a 7-year term and three consultants, each serving a 5-year term. These individuals are among the most highly respected researchers in our field. The expertise and dedication of the RAB are critical to the success of the mission of the AOS Research Foundation.